Saturday, July 11, 2026

pharma · Cervical Cancer · Non-small Cell Lung Cancer

Sichuan Baili Pharmaceutical

Sichuan Baili Pharmaceutical trial registry — 4 ClinicalTrials.gov studies with program phase, status, and indication context.

CN HQ
NMPA registrant Type
Company details
Status
Public
HQ
CN
Programs
4
Drugs
0
Patents
0
Intelligence · Clinical Trials

Sichuan Baili Pharmaceutical clinical trials

Registry index of 4 ClinicalTrials.gov studies linked to Sichuan Baili Pharmaceutical programs — each row shows trial ID, program name, phase, status, and indication.

Sichuan Baili Pharmaceutical trial registry — 4 ClinicalTrials.gov studies with program phase, status, and indication context.

Recent trial activity

4 updates

Latest clinical program signals indexed for Sichuan Baili Pharmaceutical.

  1. BL-B01D1 — Phase 2

    Clinical update
  2. BL-B01D1 — Phase 2

    Clinical update
  3. SI-B001 — Phase 2

    Clinical update
  4. BL-M07D1 — Phase 1

    Clinical update

Trial registry

4 studies